中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
15期
94-95,98
,共3页
补肺活血胶囊%生脉注射液%慢性阻塞性肺气肿%疗效
補肺活血膠囊%生脈註射液%慢性阻塞性肺氣腫%療效
보폐활혈효낭%생맥주사액%만성조새성폐기종%료효
Bufei Huoxue capsule%Shengmai injection%Chronic obstructive emphysema%Curative effect
目的：观察补肺活血胶囊联合生脉注射液治疗慢性阻塞性肺气肿的临床效果。方法将本院于2012年4月~2014年4月收治的120例慢性阻塞性肺气肿患者作为研究对象，随机将其分为对照组(n=60)与观察组(n=60)。对照组患者给予单纯生脉注射液治疗，观察组患者在此基础上加用补肺活血胶囊。比较两组的治疗效果，记录两组的肺功能改善情况。结果观察组中临床控制15例，显效31例，好转10例，总有效率为93.3%，明显高于对照组的73.3%(P<0.05)；观察组的FVC为(2.37±0.47)L，FEV1为(1.76±0.55)L，明显多于对照组，FEV1/FVC为(74.6±6.45)%，明显高于对照组(P<0.05)。结论补肺活血胶囊联合生脉注射液治疗慢性阻塞性肺气肿的临床效果显著，可明显改善患者的肺部通气功能，稳定其临床体征，值得推广。
目的：觀察補肺活血膠囊聯閤生脈註射液治療慢性阻塞性肺氣腫的臨床效果。方法將本院于2012年4月~2014年4月收治的120例慢性阻塞性肺氣腫患者作為研究對象，隨機將其分為對照組(n=60)與觀察組(n=60)。對照組患者給予單純生脈註射液治療，觀察組患者在此基礎上加用補肺活血膠囊。比較兩組的治療效果，記錄兩組的肺功能改善情況。結果觀察組中臨床控製15例，顯效31例，好轉10例，總有效率為93.3%，明顯高于對照組的73.3%(P<0.05)；觀察組的FVC為(2.37±0.47)L，FEV1為(1.76±0.55)L，明顯多于對照組，FEV1/FVC為(74.6±6.45)%，明顯高于對照組(P<0.05)。結論補肺活血膠囊聯閤生脈註射液治療慢性阻塞性肺氣腫的臨床效果顯著，可明顯改善患者的肺部通氣功能，穩定其臨床體徵，值得推廣。
목적：관찰보폐활혈효낭연합생맥주사액치료만성조새성폐기종적림상효과。방법장본원우2012년4월~2014년4월수치적120례만성조새성폐기종환자작위연구대상，수궤장기분위대조조(n=60)여관찰조(n=60)。대조조환자급여단순생맥주사액치료，관찰조환자재차기출상가용보폐활혈효낭。비교량조적치료효과，기록량조적폐공능개선정황。결과관찰조중림상공제15례，현효31례，호전10례，총유효솔위93.3%，명현고우대조조적73.3%(P<0.05)；관찰조적FVC위(2.37±0.47)L，FEV1위(1.76±0.55)L，명현다우대조조，FEV1/FVC위(74.6±6.45)%，명현고우대조조(P<0.05)。결론보폐활혈효낭연합생맥주사액치료만성조새성폐기종적림상효과현저，가명현개선환자적폐부통기공능，은정기림상체정，치득추엄。
Objective To observe the clinical effect of Bufei Huoxue capsule combined with Shengmai injection in treatment of chronic obstructive emphysema. Methods 120 cases with chronic obstructive emphysema treated in our hospital from April 2012 to April 2014 were selected as the research objects,and they were randomly divided into con-trol group (n=60) and observation group (n=60).Patients in control group were only treated with Shengmai injection, while patients in observation group were given Bufei Huoxue capsule on the basis of control group.The treatment effect between two groups was compared,and improvement of lung function in two groups was recorded. Results In observa-tion group,15 cases were clinically controlled,31 cases were markedly effective,10 cases were improved,the total effec-tive rate (93.3%) was significant higher than that of control group (73.3%) (P<0.05);FVC [(2.37±0.47) L] and FEV1 [(1.76±0.55) L] in observation group was obviously more than that of control group respectively,while FEV1/FVC [(74.6±6.45)%] was significantly higher than that of control group (P<0.05). Conclusion Clinical effect of Bufei Huoxue cap-sule combined with Shengmai injection in treatment of chronic obstructive emphysema is significant,and can improve obviously the ventilation function of lung,and stabilize the clinical signs in patients.It is worthy of promotion.
